ArticleResearch square2023

Gemcitabine elaidate and ONC201 combination therapy inhibits pancreatic cancer in a KRAS mutated syngeneic mouse model.

Ram Mahato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.